Advanced search
Publication Cover
Leukemia & Lymphoma Volume 52, 2011 - Issue 9
Submit an article Journal homepage
543
Views
23
CrossRef citations to date
0
Altmetric
Review

Current and future imaging modalities for multiple myeloma and its precursor states

Esther TanCorrespondence[email protected] [email protected]
,
Brendan M. Weiss
,
Esther MenaMolecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
,
Neha KordeMultiple Myeloma Section, Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
,
Peter L. ChoykeMolecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
&
Ola LandgrenMultiple Myeloma Section, Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USACorrespondence[email protected] [email protected]
Pages 1630-1640 | Received 24 Jan 2011, Accepted 15 Mar 2011, Published online: 08 Jun 2011

Citations (23)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Rong Li, Juan Du & Jian Hou. (2015) Identification of the potential risk factors for monoclonal gammopathy of undetermined significance of progression. Hematology 20:1, pages 11-17.
Read now

Articles from other publishers (22)

Pavel Gelezhe, Sergey Morozov, Anton Kondakov & Mikhail Beregov. 2023. Radiology‐Nuclear Medicine Diagnostic Imaging. Radiology‐Nuclear Medicine Diagnostic Imaging 772 787 .
Nicholas Bingham, Antonia Reale & Andrew Spencer. (2017) An Evidence-Based Approach to Myeloma Bone Disease. Current Hematologic Malignancy Reports 12:2, pages 109-118.
Crossref
Christos Sachpekidis, J. Hillengass, H. Goldschmidt, B. Wagner, U. Haberkorn, K. Kopka & A. Dimitrakopoulou-Strauss. (2016) Treatment response evaluation with 18F-FDG PET/CT and 18F-NaF PET/CT in multiple myeloma patients undergoing high-dose chemotherapy and autologous stem cell transplantation. European Journal of Nuclear Medicine and Molecular Imaging 44:1, pages 50-62.
Crossref
Hongwei Wu, Xiaozhen Dai & Enren Wang. (2016) Plumbagin inhibits cell proliferation and promotes apoptosis in multiple myeloma cells through inhibition of the PI3K/Akt-mTOR pathway. Oncology Letters 12:5, pages 3614-3618.
Crossref
M. E. Mayerhoefer & A. Haug. (2016) Hämatoonkologische BildgebungHemato-oncological imaging. Der Radiologe 56:7, pages 597-604.
Crossref
Giuseppe Rubini, Artor Niccoli-Asabella, Cristina Ferrari, Vito Racanelli, Nicola Maggialetti & Francesco Dammacco. (2016) Myeloma bone and extra-medullary disease: Role of PET/CT and other whole-body imaging techniques. Critical Reviews in Oncology/Hematology 101, pages 169-183.
Crossref
B Dalla Palma, D Guasco, M Pedrazzoni, M Bolzoni, F Accardi, F Costa, G Sammarelli, L Craviotto, M De Filippo, L Ruffini, P Omedè, R Ria, F Aversa & N Giuliani. (2015) Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: Role of chemokine (C-C motif) ligand 20. Leukemia 30:2, pages 409-416.
Crossref
Ik-Chan Song, Ji-Na Kim, Yoon-Seok Choi, Haewon Ryu, Myung-Won Lee, Hyo-Jin Lee, Hwan-Jung Yun, Samyong Kim, Soon Tae Kwon & Deog-Yeon Jo. (2014) Diagnostic and Prognostic Implications of Spine Magnetic Resonance Imaging at Diagnosis in Patients with Multiple Myeloma. Cancer Research and Treatment 47:3, pages 465-472.
Crossref
S.L. Giles, N.M. deSouza, D.J. Collins, V.A. Morgan, S. West, F.E. Davies, G.J. Morgan & C. Messiou. (2015) Assessing myeloma bone disease with whole-body diffusion-weighted imaging: comparison with x-ray skeletal survey by region and relationship with laboratory estimates of disease burden. Clinical Radiology 70:6, pages 614-621.
Crossref
Rosa Fonti, Leonardo Pace, Claudio Cerchione, Lucio Catalano, Barbara Salvatore, Serena De Luca, Fabrizio Pane, Marco Salvatore & Silvana Del Vecchio. (2015) 18F-FDG PET/CT, 99mTc-MIBI, and MRI in the Prediction of Outcome of Patients With Multiple Myeloma. Clinical Nuclear Medicine 40:4, pages 303-308.
Crossref
Franco Dammacco, Giuseppe Rubini, Cristina Ferrari, Angelo Vacca & Vito Racanelli. (2014) 18F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders. Clinical and Experimental Medicine 15:1, pages 1-18.
Crossref
Maximilian Merz, Judith Ritsch, Christina Kunz, Barbara Wagner, Sandra Sauer, Dirk Hose, Thomas Moehler, Stefan Delorme, Hartmut Goldschmidt, Christian Zechmann & Jens Hillengass. (2015) Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Assessment of Antiangiogenic Treatment Effects in Multiple Myeloma. Clinical Cancer Research 21:1, pages 106-112.
Crossref
Feng Xu, Frank Liu & Behram Pastakia. (2014) Different Lesions Revealed by 18F-FDG PET/CT and 18F-NaF PET/CT in Patients With Multiple Myeloma. Clinical Nuclear Medicine 39:9, pages e407-e409.
Crossref
M Merz, T Hielscher, B Wagner, S Sauer, S Shah, M S Raab, A Jauch, K Neben, D Hose, G Egerer, M-A Weber, S Delorme, H Goldschmidt & J Hillengass. (2014) Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma. Leukemia 28:9, pages 1902-1908.
Crossref
Tamás Puskás & Imre Henits. (2014) Use of whole-body diffusion-weighted magnetic resonance imaging for the diagnosis and therapeutic response of multiple myeloma. Orvosi Hetilap 155:31, pages 1241-1245.
Crossref
Sharon L. Giles, Christina Messiou, David J. Collins, Veronica A. Morgan, Catherine J. Simpkin, Sharon West, Faith E. Davies, Gareth J. Morgan & Nandita M. deSouza. (2014) Whole-Body Diffusion-weighted MR Imaging for Assessment of Treatment Response in Myeloma. Radiology 271:3, pages 785-794.
Crossref
Shi‐Cun Wang, Qiang Xie & Wei‐Fu LV. (2014) Positron emission tomography/computed tomography imaging and rheumatoid arthritis. International Journal of Rheumatic Diseases 17:3, pages 248-255.
Crossref
M Bhutani, B Turkbey, E Tan, T J Kemp, L A Pinto, A R Berg, N Korde, A R Minter, B M Weiss, E Mena, L Lindenberg, O Aras, M P Purdue, J N Hofmann, S M Steinberg, K R Calvo, P L Choyke, I Maric, K Kurdziel & O Landgren. (2013) Bone marrow angiogenesis in myeloma and its precursor disease: a prospective clinical trial. Leukemia 28:2, pages 413-416.
Crossref
Debmalya Barh, Angelo Carpi, Mukesh Verma & Mehmet GunduzMichael Byrne, Joseph Katz & Jan Moreb. 2014. Cancer Biomarkers. Cancer Biomarkers 871 908 .
Nicola Mulholland & Ming Young Simon Wan. 2013. Myeloma. Myeloma 28 38 .
Patrick J. Peller. (2013) Role of Positron Emission Tomography/Computed Tomography in Bone Malignancies. Radiologic Clinics of North America 51:5, pages 845-864.
Crossref
Nikhil C. Munshi & Kenneth C. Anderson. (2013) Minimal Residual Disease in Multiple Myeloma. Journal of Clinical Oncology 31:20, pages 2523-2526.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.